| Sticking to Efavirenz Regimen Improves Quality of Life for Treatment-Naive Patients With HIV: Presented at IDSA |
| Total Cholesterol Level Among U.S. Adults Continues to Decline |
| Use of C-Reactive Protein to Assess Cardiovascular Risk |
| 10/11/2005 | |
| Ask Patients About Herbal and Dietary Supplement Use: Presented at AAFP |
| Azithromycin/Loperamide Comparable With Levofloxacin/Loperamide for Treatment of Traveler's Diarrhea: Presented at IDSA |
| Catheter-Related Bloodstream Infection Rates in a Pediatric Population Can be Reduced by Pediatric-Relevant Intervention: Presented at AAP |
| Female High School Athletes Have Higher Rates of Injuries Than Males Playing the Same Sports: Presented at AAP |
| First Reported Hospital Outbreak of Linezolid-Resistant Enterococcus: Presented at IDSA |
| High Rate of Methicillin-Resistant Staphylococcus Infection Seen in Dalbavancin Phase 3 Trials: Presented at IDSA |
| Invasive Community-Acquired MRSA Differs From Hospital-Acquired Infections: Presented at IDSA |
| Linezolid Outpatient Treatment Costs Less Than Intravenous Vancomycin Therapy: Presented at IDSA |
| Long-Term Indinavir Treatment Keeps HIV Under Control at 156 Weeks: Presented at IDSA |
| More Aggressive Diabetes Treatment Needed: Presented at AAFP |
| MRSA Strain Analysis Provides Clues to Prognosis in Patients With Malignancies: Presented at IDSA |
| Multidrug-Resistant Acinetobacter Hitchhiking to US Military Hospitals With Wounded Soldiers: Presented at IDSA |
| New Acne Guidelines Emphasize Importance of Retinoids: Presented at AAP |
| New Guidelines Say Vaginal Birth Should Be Offered Despite Prior Cesarean: Presented at AAFP |
| Novo Nordisk Receives EU Approval of NovoMix 50 and NovoMix 70 Premixed Insulin Analogues |
| Patients With Depression and Migraine Likely to Have More Serious Disease: Presented at AAFP |
| Prospective Study Shows Gatifloxacin Triggers Hypoglycemia in Elderly Patients: Presented at IDSA |
| Racial and Ethnic Disparity Seen in Attention Deficit/Hyperactivity Diagnoses: Presented at AAP |
| Risk of Heart Attack and Cardiovascular Death Significantly Reduced by Atacand Therapy in Patients With Heart Failure |
| Standing Orders Do Not Improve Immunization Rates: Presented at AAFP |
| 10/10/2005 | |
| Breakthrough Invasive Candidiasis Reported Despite Treatment With Voriconazole or Caspofungin: Presented at IDSA |
| FDA Approves Room Temperature Storage of ZLB Behring's Helixate FS |
| No Kidney Problems Seen With Long-Term Tenofovir Treatment: Presented at IDSA |
| Proposed Guidelines Suggest Voriconazole for First-Line Treatment of Invasive Aspergillus: Presented at IDSA |
| Vancomycin In Vitro Killing Time of MRSA Correlates to Patient Outcomes: Presented at IDSA |
| 10/07/2005 | |
| Ambien CR (Zolpidem Tartrate Extended-Release Tablets) Now Available in the U.S. for the Treatment of Insomnia |
| Drug Can Reduce Risk of Death, Heart Attack, and Stroke in Diabetes Patients |
| Human Papillomavirus Vaccine 100% Effective Against Major Cancer-Causing Strains: Presented at IDSA |
| Newly Published Clinical Data Demonstrates Activity of Quadramet (samarium Sm-153 lexidronam injection) in Osteosarcoma |
| Safety Information About A Class Of Asthma Drugs Known As Long-Acting Beta-2 Agonists |
| 10/06/2005 | |
| Amoxicillin Use During Infancy May Be Linked to Tooth Enamel Defects |
| Bayer Receives FDA Approval for Room Temperature Storage of Kogenate FS (Antihemophilic Factor (Recombinant) |
| Combination Mycophenolate Mofetil (CellCept) and Interferon Beta (Rebif/Betaferon) Safe and Effective in Advanced MS: Presented at ECTRIMS |
| Early Treatment of Macular Degeneration With Macugen May Help Patients Preserve Their Vision |
| Hysterectomy Linked to Higher Levels of Inflammatory Markers Than Natural Menopause: Presented at NAMS |
| Long-Term Use of Non-COX-2-Specific NSAIDs Halves Odds for Oral Cancer But Doubles Cardiovascular Death Risk, Collaborative Study Finds |
| Minimally Invasive Endoscopic Surgery Can Safely Remove Deep Brain Tumors in Patients Without Hydrocephalus |
| Remicade (Infliximab) Receives Approval in European Union for Treatment of Moderate to Severe Plaque Psoriasis |
| Short-Term Hormone Therapy Can Improve Outlook for Early Prostate Cancer |
| Statins Use Associated with Lower Risk of Fractures |
| Study Identifies Risk Factors for Multiple Melanoma Skin Cancer |
| Test Predicts Risk of Liver Scarring After Transplant, Study Shows |
| Titration Averts Some Side Effects of Switch From Avonex to Rebif in MS Patients: Presented at ECTRIMS |
| Two-Year MOBILE Data Show Once-Monthly Oral Ibandronate to be Similar in Safety to Daily Formulation: Presented at NAMS |
| Ultra-Low Dose Menostar (Estradiol Transdermal System) Increases Bone Mineral Density: Presented at NAMS |
| 10/05/2005 | |
| Adding Niacin to Lovastatin Therapy Might Improve Efficacy for Dyslipidemia: Presented at AAFP |
| Colorectal Cancer Screening Promotion Fails to Increase Use by Physician Organizations |
| Eszopiclone Effective at Treating Menopause-Associated Insomnia: Presented at NAMS |
| FDA Approves Pfizer's Aromasin (Exemestane Tablets) for Adjuvant Treatment of Early Breast Cancer in Postmenopausal Women |
| Follistim AQ Vial Now Available in 75 IU and 150 IU Presentations |
| Kidney Paired Donation for Incompatible Donors Could Expand Donor Pool |
| MATRIX Study Shows High Patient Satisfaction with Transdermal Oxybutinin: Presented at NAMS |
| Medication With Behavioral Intervention Effective in Teen Heroin Addiction |
| New Study Finds Additional LDL-C Drops When WelChol (Colesevelam HCl) is Added to Fenofibrate in Patients with Mixed Hyperlipidemia |
| PET/CT Scans Highly Effective in Detecting Eye Cancer Metastasis |
| Pulmonary Artery Catheterization Shows No Benefit for Severe Heart Failure |
| READY Trial: Belief in Ability to Self-Inject Copaxone (Glatiramer Acetate) Appears 'Paramount' to Adherence in MS Patients: Presented at ECTRIMS |
| Schering AG Receives EU Approval for Novel Contrast Agent Vasovist |
| Shorter Course of Peg-Intron and Rebetol Combination Therapy Approved in European Union for Certain Hepatitis C Patients With Genotype 1 and Low Viral Load |
| Sports Physical Exam Can Screen Teens for Abnormal Blood Pressure: Presented at AAFP |
| Three-Year Study Shows Good Efficacy and Safety for Copaxone in MS: Presented at ECTRIMS |
| Treatment of Early Disease With Macugen (Pegaptanib Sodium Injection) May Further Reduce Risk of Vision Loss Associated With Neovascular Age-related Macular Degeneration |
| 10/04/2005 | |
| Cyclophosphamide Appears to Prolong Immunosuppression After Maximum Cumulative Mitoxantrone Dosing: Presented at ECTRIMS |
| Data and Safety Monitoring Board Recommends Discontinuation of Canvaxin Phase 3 Clinical Trial for Patients with Stage III Melanoma |
| Doxycycline Could Enhance Interferon Beta-1a (Avonex) Therapy in Relapsing-Remitting MS: Presented at ECTRIMS |
| High Blood Glucose Levels in Early Pregnancy May Deprive Embryo of Oxygen and Lead to Birth Defects, Joslin Diabetes Center Study Shows |
| Humira (adalimumab) Receives FDA Approval for First-Line Treatment of Moderate to Severe Rheumatoid Arthritis |
| Humira (Adalimumab) Receives FDA Approval for Treatment of Psoriatic Arthritis Patients on Humira Showed Substantial Improvement in Skin and Joint Symptoms of the Disease |
| Mitoxantrone for Advanced MS Stabilises Disease and Is Safe: Presented at ECTRIMS |
| Study Shows Natalizumab (Tysabri) Plus Interferon Beta-1a (Avonex) Reduces Disease Activity: Presented at ECTRIMS |
| Tirofiban Beneficial for Myocardial Perfusion and Mortality in Patients Undergoing Primary Angioplasty: Presented at ESC |
| Women Over 50 Likely to Have Both Low Bone Mineral Density and Elevated Cholesterol: Presented at NAMS |
| Xechem's Orphan Drug Status Approved for Its Sickle Cell Medicine in the European Union |
| 10/03/2005 | |
| Early-Onset Dementia Often Preventable: Presented at ANA |
| Efficacy and Safety of Interferon Beta-1a (Avonex) Appears Unaffected by Gender of Patient: Presented at ECTRIMS |
| Fast-dissolving Selegiline (Zelapar Zydis) Reduces "Off-Time" in Up to 4 Years of Follow-Up: Presented at ANA |
| Fatigue and Depression, but Not Cognitive Dysfunction, Significantly Reduces Quality-of-Life in Early MS Patients: Presented at ECTRIMS |
| Glatiramer Acetate (Copaxone) Safe for Paediatric Multiple Sclerosis: Presented at ECTRIMS |
| Hot Flashes Only Disturb Sleep the First Half of the Night: Presented at NAMS |
| Initial Disability Scores and Progression Rather Than Relapses Affect Duration of Interferon Beta-1a (Avonex) Treatment: Presented at ECTRIMS |
| Lasofoxifene Improves Symptoms of Vaginal Atrophy: Presented at NAMS |
| Lifestyle Changes Improve Neuropathic Pain in Prediabetics: Presented at ANA |
| Most Patients With Multiple Sclerosis Who Continue Therapy Have Reduced Disability, Researchers Report: Presented at ECTRIMS |
| New Analyses Show Preos (Parathyroid Hormone) Improves Bone Strength and Reduces Fracture Risk in Postmenopausal Women With Osteoporosis |
| New Hormone Replacement Therapy Effective Against Vasomotor Symptoms and Has Modest Cardiovascular Benefits: Presented at NAMS |
| Noncompliance With Multiple Sclerosis Therapy Appears Treatment Related, Affects Quality of Life: Presented at ECTRIMS |
| Patients Get More Preventive Counseling After Myocardial Infarction Than After Stroke: Presented at ANA |
| PET Useful for Evaluating Cognitive Impairment of Unknown Etiology: Presented at ANA |
| Rasagiline Effective as Monotherapy for Early Parkinson's Disease: Presented at ANA |
| Rasagiline Linked to Decreased "Off" Time in Parkinson's Disease: Presented at ANA |
| Real-Life Mitoxantrone (Novantrone) Study Confirms Efficacy, Safety With Known Risk of Malignancy: Presented at ECTRIMS |
| Sanofi Pasteur Notifies Health Care Providers of Need to Report Adverse Events Following Administration of Menactra(R) Meningococcal Vaccine |
| Sildenafil Citrate (Viagra) Increases Brain Blood Flow in MS Patients and Could Treat Cognitive Impairment Associated With the Disease: Presented at ECTRIMS |
| Stretching Exercises Enhance Botox Therapy for Spasticity in Multiple Sclerosis: Presented at ECTRIMS |
| Treatment Costs for Multiple Sclerosis Rising in Sweden: Presented at ECTRIMS |
| Unnecessary CT Scans Ordered Often for Pediatric Patients: Presented at ANA |
| Wrist Fractures Predictive of Subsequent Osteoporotic Fractures: Presented at NAMS |
| 09/30/2005 | |
| Antares Pharma's Licensee Announces First Transdermal Estradiol Gel With Three Doses That Significantly Decrease Hot Flashes in Menopausal Women |
| Body Fat Changes Are Not Common in Patients Taking HIV Drugs |
| Coiling versus Clipping in Repair of Ruptured Aneurysm: Numbers Needed to Treat Fewer than Previously Assumed: Presented at ANA |
| Common Form of Thalassaemia Can Be Managed without Blood Transfusion |
| Cortical Stimulation Improves Limb Function After Stroke: Presented at ANA |
| Evidence of New Hereditary Joint Disorder |
| FDA Advisory Committee Votes Unanimously to Recommend Approval of Exjade(R) for Once-Daily Oral Treatment of Chronic Iron Overload Due to Blood Transfusions |
| FDA Issues Public Health Advisory on Strattera (Atomoxetine) for Attention Deficit Disorder |
| Heavy Smokers May be Less Likely to Get Alzheimer's Disease: Presented at ANA |
| High Rate of Intracranial Hemorrhage Found Among African Americans Treated With Tissue Plasminogen Activator: Presented at ANA |
| Intermittent Prophylaxis Prevents Malaria in Infants |
| Lasofoxifene May Increase Bone Mineral Density (BMD) of the Spine and Hip: Presented at ASBMR |
| Long-Term Use of Glatiramer Acetate (Copaxone) for Multiple Sclerosis Appears Safe and Efficacious: Presented at ECTRIMS |
| Multiple Sclerosis Quality-of-Life Principles Set Forth Internationally: Presented at ECTRIMS |
| Nerve Changes from Diabetes Begin Earlier Than Previously Known |
| New Strategy Could Prevent Leading Cause of Maternal Death in Africa |
| Speed of PSA Rise Helps Predict Survival for Prostate Cancer Patients |
| 09/29/2005 | |
| Chromium Picolinate Linked With Reduced Carbohydrate Cravings in People With Atypical Depression |
| Clinical Signs of Lewy Body Dementia Consistent With Autopsy Findings: Presented at ANA |
| Critical Therapeutics Announces FDA Approval of Zyflo (Zileuton Tablets) for the Prevention and Chronic Treatment of Asthma |
| Dietary Linoleic Acid, APOE Genotype and Risk for Alzheimers Disease: Presented at ANA |
| Eszopiclone (Lunesta) Can Be Used Up to 6 Months without Withdrawal Symptoms: Presented at ANA |
| FDA Approves Angeliq (Drospirenone/Estradiol) to Treat Menopausal Symptoms |
| Head-to-Head Study of Treatments for Chemotherapy-Related Anemia Published in The Oncologist |
| Intracranial Hemorrhage Less Severe in Patients with Untreated Brain Arteriovenous Malformations: Presented at ANA |
| Intranasal Carbon Dioxide Relieves Migraines: Presented at ANA |
| More Than Bone Mineral Density at Work in Prevention of Fractures With Teriparatide: Presented at ASBMR |
| Most Postmenopausal Women Are Vitamin D Deficient: Presented at ASBMR |
| Most US Women Do Not Receive Osteoporosis Treatment: Presented at ASBMR |
| Multiple Sclerosis Gene Cluster Pinpointed: Presented at ANA |
| New Method Developed to Evaluate Male Fracture Risks: Presented at ASBMR |
| Palifermin (Kepivance) Appears Safe for Renally Impaired Patients: Presented at ACCP |
| Pregnancy Complications Raise Stroke Risk: Presented at ANA |
| 09/28/2005 | |
| Allergan Receives Positive Opinions for Combigan(TM) from 21 Countries in European Union |
| Allergic Rhinitis Responds to Specific Immunotherapy: Presented at AAOA |
| Fever of Unknown Origin: A Marker for Occult Cancer? |
| Insmed Receives Approvable Letter for iPlex (rhIGF-I/rhIGFBP-3) |
| Interim Results of UPLIFT Trial Show Improvement in Lung Function With Combined Anticholinergic, Beta-Adrenergic Treatment: Presented at ERS |
| Long-Term Smoking Associated With Up to 40% Increased Risk of Breast Cancer |
| New Data Provide In-Depth, Safety Information on Long-Term use of Evista(R) |
| Patients' Post-Stroke Cognitive Impairment Does Not Predict Improvement in Rehabilitation: Presented at ANA |
| Postmenopausal Women Falling Far Short of Calcium Goals: Presented at ASBMR |
| Research Suggests Caution Necessary When Prescribing Immunotherapy for Patients on Beta-Blockers: Presented at AAOA |
| Study Shows One Abnormal Site Does Not Contribute to Fracture Risk: Presented at ASBMR |
| Young Athletes May Not Need Extra Calcium: Presented at ASBMR |
| 09/27/2005 | |
| Alpha-1-Antitrypsin Replacement Therapy Every 2 or 3 Weeks May Be Feasible: Presented at ERS |
| Carotid Endarterectomy Beneficial for Stroke Prevention |
| EMEA Grants Orphan Drug Designation to Troxatyl (Troxacitabine) for Treatment of Acute Myeloid Leukemia |
| FDA Approves Pfizer's Lipitor (atorvastatin calcium) to Reduce Risk of Strokes and Heart Attacks in Patients With Diabetes |
| Healthcare Professionals Alerted to Reported Medication Errors Between Topamax and Toprol-XL |
| Imaging Tracer Clarifies Cause of Chest Pain Up to 30 Hours After Pain Stops |
| Immunotherapy Associated With Better Quality of Life in Patients With Allergic Rhinitis: Presented at AAOA |
| New Drug Shows Promise Treating Osteoporosis: Presented at ASBMR |
| Omalizumab Limits Recurrence of Nasal Polyps: Presented at AAOA |
| Once-a-Month Treatment Preferred Over Weekly for Osteoporosis: Presented at ASBMR |
| Silicon May Play Important Role in Bone Health: Presented at ASBMR |
| Specific Benefits of Statin Therapy Identified |
| Study Suggests Genetic Component to Sinonasal Polyps: Presented at AAOA |
| Treatment of Hypertension in Obese Patients Requires Caution: Presented at ACCP |
| Vancomycin Monitoring Uncommon for Pediatric Patients: Presented at ACCP |
| Xyotax (Paclitaxel Poliglumex) Significantly Prolongs Survival Among Women With Advanced Lung Cancer |
| 09/26/2005 | |
| ADHD Drugs: Effective and Generally Safe for Kids and Teens, But New Report Advises Caution on Diagnosis and Adult Use |
| Autonomic Nervous System Abnormalities Found in Patients With Allergic Rhinitis: Presented at AAOA |
| Baxter Announces the U.S. Launch of GammaGard Liquid 10% for Patients With Primary Immunodeficiency Disorders |
| Benefits Accrued Early in Heart Failure Patients Treated With Isosorbide Dinitrate and Hydralazine Therapy: Presented at HFSA |
| Biomira announces BLP25 Liposome Vaccine Phase 2B data published in Journal of Clinical Oncology |
| Cardiac Safety of Formoterol in COPD Confirmed: Presented at ERS |
| Computer-Aided system Helps Detect Breast Cancer |
| Early Treatment Prevents Future Fractures: Presented at ASBMR |
| European Drug Strontium Ranelate (Protelos) Shown to Work on Bone Formation: Presented at ASBMR |
| Exercise in Childhood Prevents Osteoporosis Later in Life: Presented at ASBMR |
| FDA Accepts Altace Supplemental New Drug Application for Delaying the Progression of Chronic Kidney Disease in Hypertensive, Non-Diabetic Patients |
| Heart Hemodynamics Improved in Acute Compensated Diastolic Heart Failure With Nesiritide: Presented at HFSA |
| Investigative Conivaptan Improved Serum Sodium Concentration in Patients With Hyponatremia: Presented at HFSA |
| Markers for Airway Inflammation Significantly Reduced in Serevent Versus Placebo Study: Presented at ERS |
| Minimally Invasive Cochlear Implantation Offers Benefits Over Traditional Procedure |
| Nesiritide Therapy Not Associated With Mortality Risk: Presented at HFSA |
| New Device Improves Fracture Predictions: Presented at ASBMR |
| New Drug Results in Less Liver Toxicity for Patients With Pulmonary Arterial Hypertension: Presented at ERS |
| Overexpression of COX-2 Seen as Important Indicator of Progressive Disease in Squamous Cell Carcinoma: Presented at ERS |
| Pooled Analysis Shows Significant Improvements With Omalizumab as Add-On Therapy: Presented at ERS |
| Quantitative Immunotherapy Shows Promise in Allergy Treatment: Presented at AAOA |
| Race a Risk Factor for Angioedema From Angiotensin-Converting Enzyme Inhibitors: Presented at AAOA |
| Rapid Onset of Action and Good Efficacy Seen in Indacaterol Dose-Ranging Study: Presented at ERS |
| Recombinant Alpha 1-Antitrypsin Shows Promise in Treating AAT Deficiency: Presented at ERS |
| Ridding Environment of Allergens Requires Serious Commitment: Presented at AAOA |
| Steroid Use Important in Control of Allergic Rhinitis: Presented at AAOA |
| Surgery Boosts Quality of Life for Child with Chronic Sinusitis |
| Treatment of COPD With Budesonide May Protect Against Heart Disease: Presented at ERS |